Cargando…

MON-LB032 Real World Evidence Data on the Role of Sodium/Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonist in Chronic Kidney Disease Stage 3 Patients beyond Glycemic Control, at Glycemia Clinic- Kuwait

Introduction Diabetes remain the most common reason for progression to end stage renal disease. Chronic kidney disease (CKD) is a strong prediction of mortality in patients with diabetes.(1) Up to 40% of type two diabetes (T2D) will eventually suffer from kidney failure.(2) Sodium/glucose Cotranspor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaghouli, Amna, Aranky, Rola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550959/ http://dx.doi.org/10.1210/js.2019-MON-LB032

Ejemplares similares

SUN-682 Type Two Diabetes Patient in Remission After Twelve Years of Diagnosis
por: Shaghouli, Amna Ali, et al.
Publicado: (2020)

SUN-694 Case Study of Nonalcoholic Steatohepatitis Reversibility in Type Two Diabetic Patient with Weight Loss Using Liraglutide
por: Shaghouli, Amna Ali, et al.
Publicado: (2020)

Management of Late Dumping Syndrome Induced Hypoglycemia With GLP-1R Agonist
por: Shaghouli, Amna Ali, et al.
Publicado: (2021)

MON-LB115 Ready-To-Use Glucagon for the Prevention of Exercise-Induced Hypoglycemia in a Clinical Research Setting
por: Aronson, Ronnie, et al.
Publicado: (2020)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

SUN-LB032 Severe Insulin Resistance and Nephrotic Range Proteinuria Reversed by Pioglitazone in a Patient With Dunnigan Type Lipodystrophy
por: Sharma, Anjul, et al.
Publicado: (2019)

MON-LB122 Psychiatric Medication Induced Diabetes Mellitus
por: Khanal, Bishal, et al.
Publicado: (2020)

MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure
por: Pettus, Jeremy H, et al.
Publicado: (2020)

SAT-LB032 Young Adult LEW.1WR1 Rats Develop Increased Glucose Intolerance on a Moderately Increased Sucrose Diet
por: Collins, Genoah, et al.
Publicado: (2019)

SUN-618 Decision Analysis for Glucagon-Like Peptide Receptor Agonists vs. Sodium-Glucose cotransporter2 Inhibitors in Type 2 Diabetes Mellitus
por: khazaali, Ali Al, et al.
Publicado: (2020)

MON-697 Necrotising Fasciitis- Importance of Glycemic Control
por: Kasireddy, Amulya Reddy, et al.
Publicado: (2020)

MON-LB024 Episodic Hypoglycemia in Non-Diabetics: Differentiating Distressing from Deadly
por: Windham, Mary, et al.
Publicado: (2019)

MON-LB031 Higher Insulin Degrading Enzyme Levels in Subjects with Metabolic Syndrome
por: Sofer, Yael, et al.
Publicado: (2019)

MON-LB127 Pulmonary Embolism in the Setting of Diabetic Ketoacidosis. an Under-Recognized Complication
por: Ahmed, Adeel Jabran, et al.
Publicado: (2020)

MON-LB119 Euglycemic Diabetic Ketoacidosis in a Patient on Canagliflozin Presenting With Hypoglycemia
por: Inkollu, Sindhura, et al.
Publicado: (2020)

MON-LB026 Critical Illness Associated Fatal Hypoglycemia in a Non-Diabetic Male
por: Toor, Amit, et al.
Publicado: (2019)

MON-LB109 Transcutaneous Magnetic Stimulation: A Novel Treatment of Diabetic Peripheral Neuropathy
por: Satyarengga, Medha, et al.
Publicado: (2020)

MON-LB025 An Artificially Low HbA1c as a Result of Dapsone Therapy
por: George, Robert, et al.
Publicado: (2019)

MON-LB128 Phosphoinositide 3-Kinase (PI3K) Inhibitor Induced Hyperglycemia With Alpelisib
por: Barsukova, Yuliya, et al.
Publicado: (2020)

MON-LB111 Evaluation of Mixed Meal Test on the Diagnosis of Hyperinsulinemic Hypoglycemia After Bariatric Surgery
por: Asato, Marilia Tomiyoshi, et al.
Publicado: (2020)

MON-LB125 Dka From a Ketogenic Diet and Intermittent Fasting or Ketosis-Prone Diabetes?
por: Athonvarangkul, Diana, et al.
Publicado: (2020)

MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020)

MON-173 Vitamin D And Glycemic Control In Type 2 Diabetes
por: Jadoon, Nauman, et al.
Publicado: (2019)

MON-LB030 Muscle Mitochondrial Oxidative Phosphorylation Capacity and Whole Body Glucose Metabolism in Friedreich's Ataxia
por: Nguyen, Sara, et al.
Publicado: (2019)

MON-LB121 New Onset Insulin Dependent Diabetes Mellitus Secondary to Treatment With Immune Checkpoint Inhibitor
por: Bitat, Syed Rabha
Publicado: (2020)

MON-LB120 MODY3 With Insulin Coding Gene Mutation and Craniofacial Microsomia: A Case Report
por: Cao, Chenxiang, et al.
Publicado: (2020)

MON-LB116 FGF-21 Is A Reliable Marker Of Insulin Resistance Before The Occurrence Of Glucose Intolerance
por: sawah, ahmed, et al.
Publicado: (2020)

MON-LB123 Diagnosis and Management of Euglycemic DKA in the Setting of SGLT2 Inhibitor Use and Prostate Abscess
por: Rameshkumar, Naveen Sundar
Publicado: (2020)

MON-632 The Effects of a High Intensity Glycemic Program on Weight and BMI
por: Guzman, Heidi, et al.
Publicado: (2020)

MON-LB034 Acanthosis Nigricans: A Predictor of Developing Type 2 Diabetes in a High Risk Population?
por: Davison, Belinda, et al.
Publicado: (2019)

MON-LB112 Socioeconomic Status, Literacy, and Sex Differences in the Progression of Retinopathy in Patients With Type 2 Diabetes in Tokyo, Japan
por: Emoto, Naoya, et al.
Publicado: (2020)

MON-624 Effect of Whole Body Vibration on Glycemic Control in Adults with Type 2 Diabetes
por: Michels, Manuela de Lucca, et al.
Publicado: (2020)

Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
por: Quadri, Hamza, et al.
Publicado: (2021)

MON-LB124 Euglycemic Diabetic Ketoacidosis on Initiation of Ertugliflozin in a Patient With Type 2 Diabetes Mellitus Precipitated by a Ketogenic Diet
por: Richstein, Ryan, et al.
Publicado: (2020)

MON-LB033 Unleashing the Anti-Inflammatory Potential of Treg Cells Against Type I Diabetes Using Advanced Chimeric Antigen Receptor Technology
por: Imam, Shahnawaz, et al.
Publicado: (2019)

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial
por: Snaith, Jennifer R, et al.
Publicado: (2020)

MON-LB126 A Benign and Favorable Diagnosis: Glycogen Hepatopathy Causing Transient Transaminitis During Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
por: Yau, Alice, et al.
Publicado: (2020)

SAT-LB120 A Software Application Delivering Behavioral Therapy Improved Glycemic Control in Adults With Type 2 Diabetes
por: Guthrie, Nicole L, et al.
Publicado: (2020)

MON-LB117 Differences in Metabolic Control, Treatment and Associated Complications in Patients Living With Type 1 Diabetes Receiving Private or Public Health Care in Mexico
por: Faradji, Raquel N, et al.
Publicado: (2020)

MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry
por: Kaiser, Nathalie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o19f4vbv16chaqm3ocai441nk6